Белоусов Ю. Б., Манешина О. А., Ерофеева С. Б. Новый взгляд на контроль частоты сердечных сокращений в снижении смертности пациентов с сердечно-сосудистыми заболеваниями: возможности ивабрадина, нового ингибитора If тока. Кардиоваскулярная терапия и профилактика. 2007;6(6):58-68.
1. Bramah N Singh Morbidity and Mortality in Cardiovascular Disorders: Impact of Reduced Heart Rate. J Cardiovasc Pharmacol Ther 2001; 6(4): 313-31.
2. Levine HJ. Rest heart rate and life expectancy. JACC 1997; 30: 1104-6.
3. R. Ferrari Editorial: heart rate. Eur Heart J 2003; (Suppl 5): G1-2.
4. Azbel MY. Universal biological scaling and mortality. Proc natl Acad Sci USA 1994; 91: 12453-7.
5. Kannel W, Wilson P, Blaire S. Epidemiologic assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J 1985; 109: 876-85.
6. Gillman M, Kannel W, Belanger A, et al. Influence of heart rate on mortality among persons with hypertension: The Framingham study. Am Heart J 1993; 125: 1148-54.
7. Gillum R, Makuc D, Feldman J. Pulse rate, coronary heart disease, and death: The NHANES I epidemiologic follow-up study. Am Heart J 1991; 121: 172-7.
8. Wilhelmsen L, Berglund G, Elmfeldt D, et al. The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 1986; 7: 279-88.
9. Benetos A, Rudnichi A, Thomas F, et al. influence of heart rate on mortality in French population – role of age, gender and blood pressure. Hypertension 1999; 33: 44-52.
10. Seccareccia F, Pannozzo F, Dima F, et al. Herat rate as a predictor of mortality: the MATISS project. Am J Public Health 2001; 91: 1258-63.
11. Okamura T, Hayakawa T, Kadowaki T, et al. NIPPONDATA80 Research Group. Resting heart rate and cause-specific death in a 16,5-year cohort study of the Japanese genereal population. Am Heart J 2004; 147: 1024-32.
12. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26: 867-74.
13. Hjalmarson A, Gilpin E, Kjekshus J, et al. Influence of heart rate on mortality after acute myocardial inferction. Am J Cardiol 1990; 65: 547-53.
14. Benetos A, Thomas F, Bean K, et al. Resting heart rate in older people: a redictor of survival to 85. J Am Geriart Soc 2003; 51: 284-5.
15. DiFrancesco D, Camm A. Heart rate Lowering by Specific and Selective If Current Inhibition with Ivabradin. Drugs 2004; 64(16): 1757-65.
16. Boyett MR, Honjo, Kodama I. The sinoatrial node a heterogeneous pacemaker struscure. Cardiovasc Rec 2000; 47: 658-87.
17. Shattock MJ. The initiation of the heart beat. Eur Heart J 1999; (Suppl H)): H11-7.
18. Boyett MR, Harrison SM, Janvier NC, et al. A list of vertebrate cardiac ioic currents: nomenclature, properties, function and clined equivalents. Cardiovasc Res 1996; 32: 455-81.
19. PapeHC. Queer current and pacemaker: the hyperpolarization-activated cation current in neurons. Ann Rev Physiol 1996; 58: 299-327.
20. Zagotta WN, Olivier NB, Black KD, et al. Structural basis for modulation and agonist specificity of HCN pacemaker channels. Nature 2003; 425: 200-5.
21. Lenfant J, Bois Patrick. Selective and Specific If inhibition in cardiovascular disease edited by Bramah N.Singh and Paul M.Vanhoutte. Lippincott Williams and Wilkins, 2003.
22. Beere P, Glagov S, Zarins C. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984; 226: 180-2.
23. Thollon C, Cambarrat C, Vian J, et al. Electrophysiological effect of S 16257, a novel sinoatrial node modulator, on rabbit and guinea-pig cardiac preparation: comparison with UL-FS49. Br J Pharmacol 1994; 112: 37-42.
24. Krayer O. Veratramine an antagonist to the cardioaccelerator of epinephrine. Proc Soc Exp Biol Med 1949; 70: 631-8.
25. Bucchi A, Baruscotti M, DiFrancesco D. Current-dependent block of rabbit sino-atrial node If channels by ivabradin. J Gen Physiol 2002; 120: 1-13.
26. DiFrancesco D. If current inhibitors: propeties of drug channel interraction. In:Fox K, ed. Selective and Specific If channel Inhibition in Cardiology. London, UK:Science Press Ltd; 2004: 1-13.
27. Vilaine JP, Bidouard JP, Lesage L, et al. Anti-ischemic effects of ivabradin , a selective heart-rate reducing agent, in exercise- induced myocardial ischemia in pigs. J Cardiovasc Pharmacol 2003; 42: 688-96.
28. Monnet X, Colin P, Ghaleh B, et al. Heart rate reduction during exercise-induced myocardial ischemia and stunning. Eur Heart J 2004; 25: 579-86.
29. Simon L, Gheleh B, Puybasset L, et al. Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 1995; 275: 659-66.
30. Vilaine JP, Thollon C, Villeneuve N, et al. Procoralan, a new selective If current inhibitor. Eur Heart J 2003; 5(Suppl G): G26-35.
31. Borer JS, Fox K, Jaillon P, et al. Antianginal and antiischemic effects of ivabradin, an If inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003; 107: 817-23.
32. Demontis GC, Moroni A, Gravante B, et al. Functional characterisation and subcellular localisation of HCN 1 channels in rabbit retinal rod photoreceptors. J Physiol 2002; 542(Pt 1): 89-97.
33. Tardif JC, Ford I, Tendera M, et al. On behalf of INITIATIVE study investigators group. Antianginal and anti-ischemic effects of the If current inhibitor ivabradine compared to atenolol as monotherapies in patients with chronic stable angina. Eur Heart J 2003; 24: Abstract 186.
34. Ruzyllo W, Ford I, Tendera M, et al. on behalf of the study investigators Antianginal and anti-ischemic effects of If current inhibitor ivabradine compared to amlodipine as monotherapy in patients with chronic stable angina: a 3-month randomized, controlled, double-blind, multicenter trial. Eur Heart J 2004; 25(Suppl.): 138.
35. Jouven X, Desnos M, Guerot C, et al. Predicting sudden death in the population: the Paris Prospective Study. Circulation 1999; 99: 1978-83.
36. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001; 104(13): 1477-82.
37. Brown HF, DiFrancesco D, Noble SJ. How does adrenaline accelerate the heart? Nature 1979; 280(5719): 235-6.
38. Шальнова СА., Деев А.Д, Оганов Р.Г. Частота пульса и смертность от сердечно-сосудистых заболеваний у российских мужчин и женщин. Результаты эпидемиологического исследования. Кардиология 2005; 10: 45-50.
